1832 Asset Management’s Transmedics TMDX Stock Holding History

1832 Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-455,445	Closed	-$71.5M	–	726
2024 Q3	$71.5M	Buy	+455,445	New	+$70.2M	0.05%	172

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

1832 Asset Management's TMDX Position: Q4 2024 in Review

1832 Asset Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 455,445 shares — an estimated $71.5M sold.

1832 Asset Management first reported a position in TMDX in Q3 2024 and held it in 1 quarter. The position peaked at $71.5M in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

1832 Asset Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
1832 Asset Management sold 455,445 Transmedics shares in Q4 2024, an estimated $71.5M.
1832 Asset Management first reported a position in Transmedics in Q3 2024 and held it in 1 quarter.
1832 Asset Management's Transmedics position peaked at $71.5M in Q3 2024.
315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on 1832 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.